REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmesis International Ltd. (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmesis International Ltd. Profile Updated: August 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

pharmesis International Ltd is a company specializing in the research, development, production, and sale of Western medicine and Traditional Chinese Medicine formulated products for liver and gall bladder illnesses. They produce tablets, granules, and pills, including ATT tablets and Gansu granules.

Headquarters
No. 8 Yingbin Road, Chengdu
Chengdu; Sichuan;

Contact Details: Purchase the Pharmesis International Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmesis International Ltd. report to view the information.
Outstanding Shares:
Purchase the Pharmesis International Ltd. report to view the information.
Financial Auditors:
Purchase the Pharmesis International Ltd. report to view the information.
Incorporation Date:
January 14, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
16.51%
Purchase this report to view the information.
15.05%
Purchase this report to view the information.
12.93%
Purchase this report to view the information.
10.88%
Purchase this report to view the information.
9.46%
Subsidiaries
Chengdu Kinna Pharmaceutical Co. Ltd. (China)
100%
Company Performance
Financial values in the chart are available after Pharmesis International Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
10.84%▲
Total operating revenue
11%▲
Operating profit (EBIT)
59.6%▲
EBITDA
N/A
Net Profit (Loss) for the Period
66.75%▲
Total Assets
5.93%▲
Total Equity
6.64%▲
Operating Profit Margin (ROS)
6.84%▲
Net Profit Margin
11.77%▲
Return on Equity (ROE)
5.32%▲
Debt/Equity
-4.49%▼
Quick Ratio
0.11%▲
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo